Avantra Family Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Avantra Family Wealth's BMY Position: Q1 2026 in Review
Avantra Family Wealth sold out of Bristol-Myers Squibb (BMY) in Q1 2026, closing a stake of 6,382 shares — an estimated $344K sold.
Avantra Family Wealth first reported a position in BMY in Q3 2025 and held it in 2 quarters. The position peaked at $344K in Q4 2025. 2,527 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Avantra Family Wealth reported no remaining Bristol-Myers Squibb position as of Q1 2026 after selling out during the quarter.
- Avantra Family Wealth sold 6,382 Bristol-Myers Squibb shares in Q1 2026, an estimated $344K.
- Avantra Family Wealth first reported a position in Bristol-Myers Squibb in Q3 2025 and held it in 2 quarters.
- Avantra Family Wealth's Bristol-Myers Squibb position peaked at $344K in Q4 2025.
- 2,527 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Avantra Family Wealth's 13F filing for Q1 2026, filed 22 Apr 2026.